Literature DB >> 12097583

Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.

Amanda D Stuart1, Thomas A McKee, Pamela A Williams, Chris Harley, Shuo Shen, David I Stuart, T David K Brown, Susan M Lea.   

Abstract

We have used X-ray crystallography to determine the structure of a decay accelerating factor (DAF)-binding, clinic-derived isolate of echovirus 11 (EV11-207). The structures of the capsid proteins closely resemble those of capsid proteins of other picornaviruses. The structure allows us to interpret a series of amino acid changes produced by passaging EV11-207 in different cell lines as highlighting the locations of multiple receptor-binding sites on the virion surface. We suggest that a DAF-binding site is located at the fivefold axes of the virion, while the binding site for a distinct but as yet unidentified receptor is located within the canyon surrounding the virion fivefold axes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097583      PMCID: PMC136386          DOI: 10.1128/jvi.76.15.7694-7704.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor.

Authors:  P R Kolatkar; J Bella; N H Olson; C M Bator; T S Baker; M G Rossmann
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

2.  In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis.

Authors:  E K Godeny; C J Gauntt
Journal:  Am J Pathol       Date:  1987-11       Impact factor: 4.307

3.  Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55.

Authors:  S M Lea; R M Powell; T McKee; D J Evans; D Brown; D I Stuart; P A van der Merwe
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

4.  Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.

Authors:  R M Powell; T Ward; D J Evans; J W Almond
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 5.  Early events in poliovirus infection: virus-receptor interactions.

Authors:  V R Racaniello
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.

Authors:  T A Martino; M Petric; M Brown; K Aitken; C J Gauntt; C D Richardson; L H Chow; P P Liu
Journal:  Virology       Date:  1998-05-10       Impact factor: 3.616

7.  A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.

Authors:  D R Shafren; D T Williams; R D Barry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Analysis of the structure of a common cold virus, human rhinovirus 14, refined at a resolution of 3.0 A.

Authors:  E Arnold; M G Rossmann
Journal:  J Mol Biol       Date:  1990-02-20       Impact factor: 5.469

9.  Identification of two determinants that attenuate vaccine-related type 2 poliovirus.

Authors:  R B Ren; E G Moss; V R Racaniello
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.

Authors:  K Klingel; C Hohenadl; A Canu; M Albrecht; M Seemann; G Mall; R Kandolf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more
  22 in total

1.  Widespread circulation of echovirus type 13 demonstrated by increased seroprevalence in Toyama, Japan, between 2000 and 2003.

Authors:  Masae Iwai; Hiromu Yoshida; Mayumi Obara; Eiji Horimoto; Kazuya Nakamura; Takenori Takizawa; Takeshi Kurata; Mineyuki Mizuguchi; Tohru Daikoku; Kimiyasu Shiraki
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

2.  Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.

Authors:  Shreeram C Nallar; Sudhakar Kalakonda; Peng Sun; Yoshihiro Ohmori; Miki Hiroi; Kazumasa Mori; Daniel J Lindner; Dhananjaya V Kalvakolanu
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

3.  Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.

Authors:  Ian G Goodfellow; David J Evans; Anna M Blom; Dave Kerrigan; J Scott Miners; B Paul Morgan; O Brad Spiller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 4.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

5.  Decay-accelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells.

Authors:  Komla Sobo; Laura Rubbia-Brandt; T David K Brown; Amanda D Stuart; Thomas A McKee
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

6.  The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Authors:  Joshua D Yoder; Javier O Cifuente; Jieyan Pan; Jeffrey M Bergelson; Susan Hafenstein
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

Review 7.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  Enhanced cellular receptor usage by a bioselected variant of coxsackievirus a21.

Authors:  E Susanne Johansson; Li Xing; R Holland Cheng; Darren R Shafren
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

9.  Enterovirus capsid interactions with decay-accelerating factor mediate lytic cell infection.

Authors:  Nicole G Newcombe; E Susanne Johansson; Gough Au; A Michael Lindberg; Richard D Barry; Darren R Shafren
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Molecular analysis of echovirus 13 isolates and aseptic meningitis, Spain.

Authors:  Ana Avellón; Inmaculada Casas; Gloria Trallero; Carmen Pérez; Antonio Tenorio; Gustavo Palacios
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.